Product NDC: | 0206-2405 |
Proprietary Name: | Zosyn |
Non Proprietary Name: | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
Active Ingredient(s): | 3; .375 g/15mL; g/15mL & nbsp; PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0206-2405 |
Labeler Name: | Wyeth Piperacillin Division of Wyeth Holdings Corporation, a subsidiary of Pfizer |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050684 |
Marketing Category: | NDA |
Start Marketing Date: | 19931101 |
Package NDC: | 0206-2405-02 |
Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0206-2405-02) > 15 mL in 1 VIAL, SINGLE-USE (0206-2405-01) |
NDC Code | 0206-2405-02 |
Proprietary Name | Zosyn |
Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0206-2405-02) > 15 mL in 1 VIAL, SINGLE-USE (0206-2405-01) |
Product NDC | 0206-2405 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19931101 |
Marketing Category Name | NDA |
Labeler Name | Wyeth Piperacillin Division of Wyeth Holdings Corporation, a subsidiary of Pfizer |
Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
Strength Number | 3; .375 |
Strength Unit | g/15mL; g/15mL |
Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |